Does TOCILIZUMAB Cause Post procedural haemorrhage? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Post procedural haemorrhage have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.0% of all adverse event reports for TOCILIZUMAB.
21
Reports of Post procedural haemorrhage with TOCILIZUMAB
0.0%
of all TOCILIZUMAB reports
3
Deaths
12
Hospitalizations
How Dangerous Is Post procedural haemorrhage From TOCILIZUMAB?
Of the 21 reports, 3 (14.3%) resulted in death, 12 (57.1%) required hospitalization, and 3 (14.3%) were considered life-threatening.
Is Post procedural haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Post procedural haemorrhage?
LEVONORGESTREL (1,106)
RIVAROXABAN (930)
ASPIRIN (618)
APIXABAN (539)
ADALIMUMAB (476)
IBRUTINIB (269)
CLOPIDOGREL BISULFATE (235)
HEPARIN (174)
WARFARIN (170)
DABIGATRAN ETEXILATE (121)
Which TOCILIZUMAB Alternatives Have Lower Post procedural haemorrhage Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE